Eurofins Announces Major Expansion in Upper Leacock Township

Eurofins Lancaster Laboratories is set to embark on a significant expansion with a $147 million investment at its Upper Leacock Township campus. This development marks a pivotal moment for the company as it seeks to enhance its biopharmaceutical testing capabilities.

Eurofins Announces Major Expansion in Upper Leacock Township

Expansion Overview

The ambitious project will introduce five- and six-story lab and office buildings, covering a combined footprint of 300,000 square feet. Construction is scheduled to commence this May, transforming an existing surface parking lot into state-of-the-art facilities that will connect with a nearby lab and office building.

The expansion is poised to generate approximately 250 new jobs, contributing to the local economy and further solidifying Eurofins’ status as one of Lancaster County’s largest employers. Currently, the campus employs around 3,000 individuals, and the addition of new roles will provide further career opportunities in the region.

Support and Funding

This expansion aligns with state initiatives to bolster the local economy, as evidenced by the announcement of $2.1 million in state grants during a visit from Governor Josh Shapiro. The funding will support Eurofins’ efforts to enhance its service offerings to global clients while maintaining a commitment to local job creation.

Neal Salerno, Senior Vice President of Eurofins BioPharma Product Testing, emphasized the company’s dedication to expanding its capabilities. He expressed pride in the opportunity to serve their international clientele better while simultaneously fostering career growth for local residents.

Historical Context

Founded in 1961, Eurofins has experienced remarkable growth, particularly following its acquisition by Luxembourg-based Eurofins in 2011. Since then, the Upper Leacock Township campus has more than doubled in size, positioning it as the largest site within Eurofins’ global network of laboratories.

The planned expansion builds on previous developments, including an eight-story parking garage completed in 2019, which added 1,249 parking spaces. Salerno had previously indicated that the campus was designed with future expansion in mind, demonstrating foresight in accommodating growth.

Community Impact

The Upper Leacock Township Supervisors recently approved the plans for this expansion, highlighting community support for initiatives that promise economic benefits. The project not only enhances Eurofins’ operational capacity but also contributes to the local workforce by providing new employment opportunities.

As the biopharmaceutical industry continues to evolve, companies like Eurofins are essential to ensuring that testing services keep pace with emerging advancements. The expansion will enable Eurofins to maintain its competitive edge and support the research and development needs of its clients in the pharmaceutical sector.

Future Prospects

With the groundwork laid for this substantial expansion, Eurofins is well-positioned to enhance its service offerings. The investment in advanced facilities signifies a commitment to innovation and excellence in biopharmaceutical testing.

The expansion is a testament to the growing demand for testing services in the biopharmaceutical sector, underscoring the importance of reliable and efficient testing laboratories in the development of new therapies and medicines.

Key Takeaways

  • Eurofins Lancaster Laboratories is investing $147 million in a major expansion of its Upper Leacock Township campus.
  • The project will create approximately 250 new jobs and cover 300,000 square feet with new lab and office space.
  • The expansion aligns with state funding efforts, receiving $2.1 million in grants to support local economic growth.
  • Founded in 1961, Eurofins has significantly increased its workforce and operational capacity since its acquisition in 2011.

In conclusion, Eurofins’ upcoming expansion in Upper Leacock Township represents a significant leap forward for both the company and the local community. This investment not only bolsters Eurofins’ capabilities in biopharmaceutical testing but also nurtures job creation and economic growth in the region. As the company continues to evolve, it will undoubtedly play a crucial role in the future of life sciences.

Read more → lancasteronline.com